Hypoglycaemia - Clinical trials 

  • Clinical trials

Clinical trials for Hypoglycaemia

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Hypoglycaemia. For all clinical trials, go to clinical trials search

This list shows clinical trials for Hypoglycaemia

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Hypoglycaemia
Title Recruitment status Location
Prevention of recurrent severe hypoglycaemia: optimised multiple daily insulin injection (MDI) versus continuous subcutaneous insulin infusion (CSII) with or without adjunctive real-time continuous glucose monitoring Recruiting United Kingdom
Advantage of using Glucophage® SR (a Metofrmin) in non-overweight patients with type-1 Diabetes to improve their glucose control Recruiting United Kingdom
Do Sulphonylureas Preserve Cortical Function During Hypoglycaemia? Recruiting United Kingdom
Study of Glucophage® SR iin patients with type 2 diabetes and moderate Kidney dysfunction Recruiting United Kingdom
TARGET GLYCEMIC CONTROL AND THE INCIDENCE OF DOCUMENTED SYMPTOMATIC HYPOGLYCEMIA IN INSULIN NAÏVE SUBJECTS WITH TYPE 2 DIABETES FAILING ON ORAL HYPOGLYCEMIC AGENT(S) AND TREATED WITH LANTUS (INSULIN GLARGINE) OR LEVEMIR (INSULIN DETEMIR): MULTICENTER, MULTINATIONAL, RANDOMIZED, OPEN-LABEL, COMPARATIVE, PARALLEL-GROUP STUDY - L2T3 Not Recruiting United Kingdom
Lantus Versus Levemir Treat-To-Target Not recruiting United Kingdom
The effect of intensive blood glucose control with insulin on markers of short and medium term outcomes in patients hospitalised with acute exacerbations of chronic lung disease. Pilot Study to test feasibility and safety of a clinical protocol for intensive blood glucose control with insulin on medical wards - Pilot of Intensive Blood Glucose Control with Insulin on Medical Wards Not Recruiting United Kingdom
Use of Diazoxide in Acute Hypoglycaemia Not recruiting United Kingdom
Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia Not recruiting United Kingdom
TARGET GLYCEMIC CONTROL AND THE INCIDENCE OF DOCUMENTED SYMPTOMATIC HYPOGLYCEMIA IN INSULIN NAÏVE SUBJECTS WITH TYPE 2 DIABETES FAILING ON ORAL HYPOGLYCEMIC AGENT(S) AND TREATED WITH LANTUS (INSULIN GLARGINE) OR LEVEMIR (INSULIN DETEMIR): MULTICENTER, MULTINATIONAL, RANDOMIZED, OPEN-LABEL, COMPARATIVE, PARALLEL-GROUP STUDY - L2T3 Not Recruiting United Kingdom
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member